Philips reported solid performance in Q3 2025 with sales of €4.3 billion, a 3.3% increase in comparable terms. Net income and operating income both showed strength, supported by margin expansion and cost discipline. Strong order intake and growth across all segments underscored the company’s momentum.

Philips achieved 1% sales growth and improved profitability in Q2 2025, driven by strong order intake and AI-powered innovations. The company raised its full-year margin and cash flow outlook while maintaining sales growth guidance.

Philips reported a positive Q1 2025 with a return to net income of €72M, supported by strong personal health performance and North American demand. However, overall revenue declined slightly due to significant sales drops in China.

Philips saw a slight increase in comparable sales, driven by strong performance in Connected Care despite a significant decline in China. The company improved profitability with a higher Adjusted EBITA margin and increased free cash flow. However, net income declined due to higher tax expenses.